1. Guideline on the non-clinical investigation of the dependence potential of medicinal products;Anon,2006
2. Differences among conventional, atypical and novel putative D2/5-HT1A antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys;Auclair;Behavioural Brain Research,2009
3. The three Rs: The way forward: The report and recommendations of ECVAM Workshop 11;Balls;Alternatives to laboratory animals,1995
4. Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: Exploring new territory using traditional tools and established maps;Bartus;Psychopharmacology,2009
5. Logical principles for the development of animal models of age-related memory impairments;Bartus,1983